The Comparative Safety and Effectiveness of Bivalirudin Versus Heparin Monotherapy in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

BACKGROUND: Dialysis patients are at a higher risk of bleeding after PCI; however, due to their exclusion from randomized clinical trials, the optimal antithrombotic regimen for this population remains unknown. We sought to evaluate the comparative safety and effectiveness of bivalirudin monotherapy...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Catheter Cardiovasc Interv
Κύριοι συγγραφείς: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Khandelwal, Akshay, Cannon, Louis A., LaLonde, Thomas A., Gurm, Hitinder S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2017
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850212/
https://ncbi.nlm.nih.gov/pubmed/28303632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccd.27001
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια